{"acne": 3.74, "acquired gene mutation": 13.83, "amylase increased": 2.13, "aplastic anaemia": 3.14, "blood creatine phosphokinase increased": 3.83, "blood sodium decreased": 2.91, "brain neoplasm": 7.97, "brain oedema": 4.42, "carcinoembryonic antigen increased": 41.89, "cardiac dysfunction": 10.61, "cardiac failure": 8.79, "cardiac failure acute": 5.8, "cardiac failure chronic": 3.88, "cardiac failure congestive": 2.25, "cardiac tamponade": 5.74, "cardiomyopathy": 6.88, "cardiotoxicity": 6.74, "cerebral infarction": 2.93, "colon cancer": 2.47, "conjunctivitis": 2.32, "cutaneous vasculitis": 4.41, "decreased appetite": 3.16, "dermatitis": 4.51, "dermatitis acneiform": 20.4, "diarrhoea": 3.3, "dilated cardiomyopathy": 3.47, "disease progression": 2.37, "drug eruption": 4.57, "drug resistance": 5.34, "drug-induced liver injury": 2.27, "dry eye": 2.29, "dry skin": 10.13, "egfr gene mutation": 40.73, "ejection fraction decreased": 12.3, "electrocardiogram qt prolonged": 26.55, "erythema multiforme": 8.85, "feeding disorder": 3.17, "femur fracture": 2.84, "fracture": 3.72, "gastrooesophageal reflux disease": 2.05, "general physical health deterioration": 2.12, "haematotoxicity": 2.9, "haemoptysis": 2.82, "heart failure with reduced ejection fraction": 30.08, "hepatic cytolysis": 2.32, "hepatic function abnormal": 3.85, "hypophagia": 2.67, "interstitial lung disease": 49.31, "keratitis": 22.03, "liver disorder": 4.49, "long qt syndrome": 29.94, "lung disorder": 10.59, "lung infiltration": 2.52, "lung neoplasm malignant": 10.23, "lung opacity": 24.48, "lymphangiosis carcinomatosa": 49.92, "malignant neoplasm progression": 18.26, "malignant pleural effusion": 15.82, "metastases to bone": 15.57, "metastases to central nervous system": 40.48, "metastases to liver": 7.25, "metastases to lung": 6.49, "metastases to lymph nodes": 7.07, "metastases to meninges": 64.4, "metastases to pleura": 24.05, "metastases to spine": 15.97, "metastasis": 18.79, "mouth ulceration": 2.26, "mucosal disorder": 9.36, "mucosal inflammation": 3.6, "myelosuppression": 3.36, "nail bed inflammation": 87.6, "nail disorder": 32.91, "neoplasm progression": 2.01, "neutrophil count decreased": 2.43, "no adverse event": 3.03, "non-small cell lung cancer": 6.38, "onychoclasis": 38.59, "paronychia": 121.2, "pericardial effusion": 3.34, "platelet count decreased": 4.75, "pleural effusion": 9.47, "pneumonia aspiration": 2.42, "pneumonia bacterial": 7.01, "pneumonitis": 35.25, "pneumothorax": 7.53, "pulmonary alveolar haemorrhage": 4.51, "pulmonary embolism": 2.68, "pulmonary fibrosis": 2.53, "pulmonary mass": 3.01, "pulmonary oedema": 3.44, "pulmonary toxicity": 95.24, "pustule": 3.53, "rash": 2.55, "respiratory failure": 3.57, "sars-cov-2 test negative": 9.16, "skin disorder": 4.62, "skin exfoliation": 2.22, "skin fissures": 17.72, "skin toxicity": 6.88, "skin ulcer": 2.43, "small cell lung cancer": 21.12, "stevens-johnson syndrome": 3.16, "stomatitis": 6.43, "taste disorder": 3.2, "thrombocytopenia": 4.68, "torsade de pointes": 5.8, "toxic skin eruption": 2.87, "tumour marker increased": 10.09, "ventricular tachycardia": 2.59, "white blood cell count decreased": 2.39}